|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
MAY POTENTIALLY INCREASE THE RISK FOR ACETAMINOPHEN INDUCED HEPATOTOXICITY
|
INCREASED RISK OF MYOCARDIAL DEPRESSION
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
ORAL CONTRACEPTIVES EFFICACY IS REDUCED
|
PROPOXYPHENE & DEXTROPROPOXYPHENE INHIBIT LIVER METABOLISM OF BENZODIAZEPINES, BETABLOCKERS, CARBAMAZEPINE, PHENYTOIN & WARFARIN, SO REDUCE THEIR DOSE BY 1/3
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY INCREASE ITS SERUM CONCENTRATION
|
H-2 RECEPTOR ANTAGONIST LIKE CIMETIDINE MAY INCREASE ITS SERUM CONCENTRATION
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CORTICOSTEROIDS PLASMA CONCENTRATION IS REDUCED & HENCE EFFICACY AS ITS METABOLISM IS INCREASED WITH CONCURRENT USE
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
CALCIUM SALTS INTERFERE WITH ITS ABSORPTION FROM THE GUT
|
MICONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
POTENTIAL FOR CHANGE IN SERUM PHENYTOIN LEVELS ( INCREASED OR DECREASED)
|
CONCURRENT USE OF ERYTHROMYCIN IN PATIENTS RECEIVING DRUGS METABOLIZED BY THE CYTOCHROME P450 SYSTEM MAY BE ASSOCIATED WITH ELEVATION IN SERUM LEVELS OF PHENYTOIN
|
CONCURRENT USE OF ERYTHROMYCIN IN PATIENTS RECEIVING DRUGS METABOLIZED BY THE CYTOCHROME P450 SYSTEM MAY BE ASSOCIATED WITH ELEVATION IN SERUM LEVELS OF PHENYTOIN
|
CONCURRENT USE OF ERYTHROMYCIN IN PATIENTS RECEIVING DRUGS METABOLIZED BY THE CYTOCHROME P450 SYSTEM MAY BE ASSOCIATED WITH ELEVATION IN SERUM LEVELS OF PHENYTOIN
|
CONCURRENT USE OF ERYTHROMYCIN IN PATIENTS RECEIVING DRUGS METABOLIZED BY THE CYTOCHROME P450 SYSTEM MAY BE ASSOCIATED WITH ELEVATION IN SERUM LEVELS OF PHENYTOIN
|
CONCURRENT USE OF ERYTHROMYCIN IN PATIENTS RECEIVING DRUGS METABOLIZED BY THE CYTOCHROME P450 SYSTEM MAY BE ASSOCIATED WITH ELEVATION IN SERUM LEVELS OF PHENYTOIN
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|